Landmark Multiple Myeloma Studies from Winship

In recognition of September being Blood Caner Awareness Month, Dr. Sagar Lonial, Winship’s Chief Medical Officer shares a video about his Winship phase III clinical trial study on elotuzumab in treating myeloma patients.

Many cancers have benefited from FDA approvals for monoclonal antibodies (mAbs). Multiple myeloma, a second common blood cancer, had limited outcome improvements with mAbs until Dr. Lonial’s recent work. Dr. Lonial’s research was presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting and was published in the New England Journal of Medicine earlier this year.

Learn more about Winship Cancer Institute of Emory University.

Tags: , , , ,